跳至主要内容
临床试验/CTRI/2022/12/048573
CTRI/2022/12/048573尚未招募Unknown

A prospective, randomized, double-blind, placebo-controlled parallel-group clinical trial to evaluate the effects of a Bacillus coagulans-based product on protein digestion and utilization in gastro-intestinal tract

Abode Biotec India Private Limited1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年2月1日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
50
试验地点
1
主要终点
1.Primary outcome measure(s) will be change from baseline in Creatine Kinase and CRP

研究概览

简要总结

Probiotics are live microorganisms promoted with claims that they provide health benefits when consumed, generally by improving or restoring the gut flora. Probiotics are live bacteria and yeasts that are good for us especially for the digestive system. Probiotics are considered generally safe to consume.

The sponsor has developed the probiotic strain of BC, called as ProBCPlus. The aim of the current clinical trial is to evaluate the effects of a Bacillus coagulans-based product on protein digestion and utilization in gastro-intestinal tract in healthy human volunteers.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Subject has provided written and dated informed consent to participate in the study.
  • 2.Subject is willing and able to comply with the protocol.
  • 3.Healthy male/female of age 18-60 years.
  • 4.Subject is in good health as determined by a health history questionnaire.

排除标准

  • 1.Subject has a known allergy or sensitivity to any ingredient in the test product.
  • 2.Subject on protein and/ or probiotic rich diet.
  • 3.Subject has a history of alcohol or other drug abuse in the past year.

结局指标

主要结局

1.Primary outcome measure(s) will be change from baseline in Creatine Kinase and CRP

时间窗: 8 weeks

Score (measured after exercise bout) at day 1, week 4 and week8.

时间窗: 8 weeks

次要结局

  • Improvement in the symptoms and signs of protein absorption and digestion, based on evaluation on Creatine Kinase and CRP and Pain VAS for muscle soreness, at the end of therapy.(8 weeks)

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验